Please provide your email address to receive an email when new articles are posted on . Long-term follow-up from DANAMI-3-PRIMULTI shows reduction in events after complete revascularization vs.

Current society guidelines recommend physiological assessment of intermediate coronary lesions to guide revascularization. Data regarding revascularization guided by vessel fractional flow reserve ...

PARIS, France—Complete revascularization guided by fractional flow reserve (FFR) remains superior to treating just the culprit lesion more than a decade on in STEMI patients with multivessel disease, ...

For patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease, 10-year data from the DANAMI-3-PRIMULTI trial brought greater assurance that complete revascularization ...

WASHINGTON, DC—In patients with chronic limb-threatening ischemia (CLTI), delays longer than 30 days from the time of diagnosis to initiation of endovascular revascularization are associated with an ...

Study reveals diminished quality of life among patients with chronic limb-threatening ischemia, a severe form of peripheral artery disease, and emphasizes the benefits of revascularization on ...

Data from the PROMISE III trial suggest that chronic limb-threatening ischemia (CLTI) patients with no other treatment ...

The AHA's scientific statement on coronary artery revascularization in older adults proposes an individualized, patient-centered approach that accounts for age-related physiologic changes and ...

Transmyocardial revascularization is a procedure that uses lasers to improve blood flow in the arteries that feed the heart. It may help people who have severe forms of coronary artery disease.

Improvements in medical therapy, carotid-artery stenting, and carotid endarterectomy call into question the preferred management of asymptomatic carotid stenosis. Whether adding revascularization to ...